• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter by Koh Regarding Article, "Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: 16 Years of Follow-Up of the LIPID Study".

作者信息

Koh Kwang Kon

机构信息

From Department of Cardiovascular Medicine, Heart Center, Gachon University Gil Medical Center, Incheon, Korea; and Gachon Cardiovascular Research Institute, Incheon, Korea.

出版信息

Circulation. 2016 Sep 27;134(13):e294-5. doi: 10.1161/CIRCULATIONAHA.116.023680.

DOI:10.1161/CIRCULATIONAHA.116.023680
PMID:27672200
Abstract
摘要

相似文献

1
Letter by Koh Regarding Article, "Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: 16 Years of Follow-Up of the LIPID Study".科关于文章《普伐他汀对冠心病患者的长期有效性和安全性：LIPID研究的16年随访》的信。
Circulation. 2016 Sep 27;134(13):e294-5. doi: 10.1161/CIRCULATIONAHA.116.023680.
2
Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.普伐他汀对9014例冠心病及胆固醇浓度正常患者的长期有效性和安全性：血脂干预试验随访
Lancet. 2002 Apr 20;359(9315):1379-87. doi: 10.1016/S0140-6736(02)08351-4.
3
Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.普伐他汀对1516例冠心病女性患者心血管事件及死亡率的影响：缺血性疾病普伐他汀长期干预研究（LIPID研究）结果
Am Heart J. 2003 Apr;145(4):643-51. doi: 10.1067/mhj.2003.1.
4
Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study.普伐他汀对冠心病患者的长期有效性及安全性：LIPID研究16年随访
Circulation. 2016 May 10;133(19):1851-60. doi: 10.1161/CIRCULATIONAHA.115.018580. Epub 2016 Mar 25.
5
Long-term follow-up of the West of Scotland Coronary Prevention Study.苏格兰西部冠心病预防研究的长期随访
N Engl J Med. 2008 Jan 10;358(2):194; author reply 194-5.
6
Long-term follow-up of the West of Scotland Coronary Prevention Study.苏格兰西部冠心病预防研究的长期随访
N Engl J Med. 2008 Jan 10;358(2):193; author reply 194-5. doi: 10.1056/NEJMc076463.
7
Pravastatin. A pharmacoeconomic review of its use in primary and secondary prevention of coronary heart disease.普伐他汀。对其在冠心病一级和二级预防中应用的药物经济学综述。
Pharmacoeconomics. 1998 Aug;14(2):217-36. doi: 10.2165/00019053-199814020-00010.
8
Pravastatin and coronary heart disease.普伐他汀与冠心病
N Engl J Med. 1999 Apr 8;340(14):1115-6; author reply 1116-7. doi: 10.1056/NEJM199904083401413.
9
Long-term follow-up of the West of Scotland Coronary Prevention Study.苏格兰西部冠心病预防研究的长期随访
N Engl J Med. 2007 Oct 11;357(15):1477-86. doi: 10.1056/NEJMoa065994.
10
Long-term follow-up of the West of Scotland Coronary Prevention Study.苏格兰西部冠心病预防研究的长期随访
N Engl J Med. 2008 Jan 10;358(2):193-4; author reply 194-5.

引用本文的文献

1
Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events.将强效他汀类药物疗法与其他药物联合使用，以优化心血管和代谢方面的同步获益，同时将不良事件降至最低。
Korean Circ J. 2017 Jul;47(4):432-439. doi: 10.4070/kcj.2016.0406. Epub 2017 Jul 26.